InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients - the LIAISON study protocol

BMC Pulmonary Medicine

Volumn 13, Issue 1, 2013, Pages

  Braido, Fulvio ^a   Brusselle, Guy ^b   Ingrassia, Eleonora ^c   Nicolini, Gabriele ^c   Price, David ^d   Roche, Nicolas ^e   Soriano, Joan B ^f   Worth, Heinrich ^g  

^a UNIVERSITY OF GENOA   (Italy)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c CHIESI FARMACEUTICI S P A   (Italy)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e HÔTEL DIEU   (France)

^f Recinte Hospital Joan March   (Spain)

^g KLINIKUM FÜRTH   (Germany)

Author keywords

ACQ; Asthma control; LIAISON; Observational study; Patient reported outcomes; Quality of life

Indexed keywords

ANTIASTHMATIC AGENT;

ADULT; ARTICLE; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CONTROL; EUROPE; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINI ASTHMA QUALITY OF LIFE QUESTIONNAIRE; MORISKY MEDICATION ADHERENCE SCALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREVALENCE; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION;

ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; HEALTH STATUS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LONGITUDINAL STUDIES; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RESEARCH DESIGN;

EID: 84875344622     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-13-18     Document Type: Article

References (33)

1. GINA report, global strategy for asthma management and prevention 2012, http://www.ginasthma.org/ 2011 Accessed September.
2. Bousquet J, Kiley J, Bateman ED, Viegi G, Cruz AA, Khaltaev N, Aït Khaled N, Baena-Cagnani CE, Barreto ML, Billo N, Canonica GW, Carlsen KH, Chavannes N, Chuchalin A, Drazen J, Fabbri LM, Gerbase MW, Humbert M, Joos G, Masjedi MR, Makino S, Rabe K, To T, Zhi L. Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J 2010, 36(5):995-1001. 10.1183/09031936.00012610, 20223919.
3. Accordini S, Corsico AG, Braggion M, Gerbase MW, Gislason D, Gulsvik A, Heinrich J, Janson C, Jarvis D, Jõgi R, Pin I, Schoefer Y, Bugiani M, Cazzoletti L, Cerveri I, Marcon A, de Marco R. The cost of persistent asthma in Europe: an international population-based study in adults. Int Arch Allergy Immunol 2012, 160(1):93-101.
4. Levy ML. Guideline-defined asthma control: a challenge for primary care. Eur Respir J 2008, 31:229-231. 10.1183/09031936.00157507, 18238943.
5. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE, GOAL Investigators Group Can guideline-defined asthma control be achieved? The gaining optimal asthma controL study. Am J Respir Crit Care Med 2004, 170:836-844. 10.1164/rccm.200401-033OC, 15256389, GOAL Investigators Group.
6. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, Weiss ST. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004, 114(1):40-47. 10.1016/j.jaci.2004.04.042, 15241342.
7. Stanford RH, Gilsenan AW, Ziemiecki R, Zhou X, Lincourt WR, Ortega H. Predictors of uncontrolled asthma in adult and pediatric patients: analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCESS). J Asthma 2010, 47(3):257-262. 10.3109/02770900903584019, 20210612.
8. Liu AH, Gilsenan AW, Stanford RH, Lincourt W, Ziemiecki R, Ortega H. Status of asthma control in pediatric primary care: results from the pediatric Asthma Control Characteristics and Prevalence Survey Study (ACCESS). J Pediatr 2010, 157(2):276-281. 10.1016/j.jpeds.2010.02.017, 20472251.
9. Mintz M, Gilsenan AW, Bui CL, Ziemiecki R, Stanford RH, Lincourt W, Ortega H. Assessment of asthma control in primary care. Curr Med Res Opin 2009, 25(10):2523-2531. 10.1185/03007990903218655, 19708765.
10. Mehuys E, Van Bortel L, Annemans L, Remon JP, Van Tongelen I, Van Ganse E, Laforest L, Chamba G, Brusselle G. Medication use and disease control of asthmatic patients in Flanders: a cross-sectional community pharmacy study. Respir Med 2006, 100(8):1407-1414. 10.1016/j.rmed.2005.11.013, 16386885.
11. Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006, 6:13. 10.1186/1471-2466-6-13, 1483837, 16772035.
12. Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I, Accordini S, Almar E, Bugiani M, Carolei A, Cerveri I, Duran-Tauleria E, Gislason D, Gulsvik A, Jõgi R, Marinoni A, Martínez-Moratalla J, Vermeire P, de Marco R. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol 2007, 120(6):1360-1367. 10.1016/j.jaci.2007.09.019, 17981317.
13. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999, 14:902-907. 10.1034/j.1399-3003.1999.14d29.x, 10573240.
14. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004, 113:59-65. 10.1016/j.jaci.2003.09.008, 14713908.
15. Van der Meer V, van Stel HF, Bakker MJ, Roldaan AC, Assendelft WJ, Sterk PJ, Rabe KF, Sont JK, SMASHING (Self-Management of Asthma Supported by Hospitals, ICT, Nurses and General practitioners) Study Group Weekly self-monitoring and treatment adjustment benefit patients with partly controlled and uncontrolled asthma: an analysis of the SMASHING study. Respiratory Research 2010, 11:74. 10.1186/1465-9921-11-74, 2893513, 20537124, SMASHING (Self-Management of Asthma Supported by Hospitals, ICT, Nurses and General practitioners) Study Group.
16. Demoly P, Paggiaro P, Plaza V, Bolge SC, Kannan H, Sohier B, Adamek L. Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK. Eur Respir Rev 2009, 18(112):105-112. 10.1183/09059180.00001209, 20956130.
17. Demoly P, Gueron B, Annunziata K, Adamek L, Walters RD. Update on asthma control in five European countries: results of a 2008 survey. Eur Respir Rev 2010, 19(116):150-157. 10.1183/09059180.00002110, 20956184.
18. Allegra L, Cremonesi G, Girbino G, Ingrassia E, Marsico S, Nicolini G, Terzano C. PRISMA (PRospectIve Study on asthMA control) Study Group: Real-life prospective study on asthma control in Italy: cross-sectional phase results. Respir Med 2012, 106(2):205-214. 10.1016/j.rmed.2011.10.001, 22035853.
19. Bettoncelli G, Magnoni MS, Fassari C, Tosatto R, Di Blasi P, De Marco R, Novelletto BF, Mazzaglia GP, Caramori G, Studio P.A.C.I.S. (Point out Asthma Control Italian Survey) Il controllo dell'asma in Italia misurato con ACT (Asthma Control Test). Società Italiana di Medicina Generale 2006, 6:10-17. Studio P.A.C.I.S. (Point out Asthma Control Italian Survey).
20. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000, 16(5):802-807. 10.1183/09031936.00.16580200, 11153575.
21. De Marco R, Bugiani M, Cazzoletti L, Carosso A, Accordini S, Buriani O, Carrozzi L, Dallari R, Giammanco G, Ginesu F, Marinoni A, Lo Cascio V, Poli A, Struzzo P, Janson C, ISAYA study group The control of asthma in Italy. A multicentre descriptive study on young adults with doctor diagnosed current asthma. Allergy 2003, 58(3):221-228. 10.1034/j.1398-9995.2003.00059.x, 12653796, ISAYA study group.
22. Haughney J, Price D, Kaplan A, Chrystyn H, Horne R, May N, Moffat M, Versnel J, Shanahan ER, Hillyer EV, Tunsäter A, Bjermer L. Achieving asthma control in practice: understanding the reasons for poor control. Respir Med 2008, 102(12):1681-1693. 10.1016/j.rmed.2008.08.003, 18815019.
23. Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 1999, 14:32-38. 10.1034/j.1399-3003.1999.14a08.x, 10489826.
24. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care 1986, 24:67-74. 10.1097/00005650-198601000-00007, 3945130.
25. Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol 2011, 64(3):255-257. discussion 258-263, 10.1016/j.jclinepi.2010.09.002, 3109729, 21144706.
26. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O'Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE, American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009, 180(1):59-99. 10.1164/rccm.200801-060ST, 19535666, American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations.
27. O'Byrne PM, Reddel HK, Eriksson G, Ostlund O, Peterson S, Sears MR, Jenkins C, Humbert M, Buhl R, Harrison TW, Quirce S, Bateman ED. Measuring asthma control: a comparison of three classification systems. Eur Respir J 2010, 36(2):269-276. 10.1183/09031936.00124009, 20110397.
28. Ehrs PO, Nokela M, Ställberg B, Hjemdahl P, Jonsson EW. Brief Questionnaires for Patient-Reported Outcomes in Asthma Validation and Usefulness in a Primary Care Setting. Chest 2006, 129:925-932. 10.1378/chest.129.4.925, 16608940.
29. McLeish AC, Zvolensky MJ. Asthma and cigarette smoking: a review of the empirical literature. J Asthma 2010, 47(4):3452-3461.
30. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003, 124:474-481. 10.1378/chest.124.2.474, 12907531.
31. Briggs AH, Bousquet J, Wallace MV, Busse WW, Clark TJ, Pedersen SE, Bateman ED. Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy 2006, 61:531-536. 10.1111/j.1398-9995.2006.01038.x, 16629780.
32. Williams SA, Wagner S, Kannan H, Bolge SC. The association between asthma control and health care utilization, work productivity loss and health-related quality of life. J Occup Environ Med 2009, 51(7):780-785. 10.1097/JOM.0b013e3181abb019, 19528828.
33. Honkoop PJ, Loymans RJ, Termeer EH, Snoeck-Stroband JB, Bakker MJ, Assendelft WJ, Sterk PJ, Ter Riet G, Schermer TR, Sont JK. Asthma control cost-utility randomized trial evaluation (ACCURATE): the goals of asthma treatment. BMC Pulm Med 2011, 11:53. 10.1186/1471-2466-11-53, 3295696, 22114896.